TCF7L2 rs6718711: Understanding Your Genetic Variant
The rs6718711 variant is a common genetic marker located within the TCF7L2 gene. It is frequently studied for its statistical association with type 2 diabetes risk and the regulation of insulin secretion in the body.
What each genotype means
Typical diabetes risk profile
This genotype is considered the non-risk or baseline profile for this variant. Research indicates that individuals with this genotype do not carry the specific genetic marker associated with increased susceptibility to type 2 diabetes at this location.
This is the most common genotype observed in most global populations.
Increased diabetes risk marker
Carrying one copy of the T allele is associated with a statistically higher risk of developing type 2 diabetes compared to those without it. Research suggests this may be linked to impaired insulin secretion from pancreatic beta cells, though this is a complex trait influenced by many other genetic and lifestyle factors.
This genotype is common, found in a significant portion of the population across various ancestries.
Elevated diabetes risk marker
Carrying two copies of the T allele is associated with a higher statistical risk of type 2 diabetes than carrying one or zero copies. Studies suggest this genotype may influence how the body regulates insulin secretion, and you should discuss your overall metabolic health and diabetes prevention strategies with your healthcare provider.
This genotype is less common than the heterozygous CT state but is still frequently observed in many populations.
What is the rs6718711 Variant?
The rs6718711 variant is a single nucleotide polymorphism (SNP) found within the TCF7L2 gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is located in a non-coding region of the gene, meaning it does not directly provide instructions for building a protein. Instead, such variants often influence how genes are turned on or off, or how much of a specific protein is produced. Because TCF7L2 is a well-studied gene in the context of metabolic health, researchers track variants like rs6718711 to understand how subtle differences in our DNA sequence might correlate with physiological traits, such as how the body processes glucose or secretes insulin.
The Role of the TCF7L2 Gene
The TCF7L2 gene encodes a transcription factor, which is a protein that helps control the activity of other genes. Transcription factors act like switches, determining when and how much of a gene's product is made. TCF7L2 is particularly important in the development and function of the pancreas, specifically within the beta cells that produce insulin. Research suggests that variations in this gene can influence the enteroinsular axis, a system that links the gut to the pancreas to regulate insulin release after eating. When TCF7L2 expression is altered, it may impair the body's ability to secrete insulin effectively in response to glucose, which is a key factor in maintaining healthy blood sugar levels.
Research and Statistical Associations
The TCF7L2 gene is widely recognized as one of the most significant genetic loci associated with type 2 diabetes risk. Numerous studies have shown that common variants in this gene are linked to impaired beta-cell function and reduced insulin response to glucose. While the evidence for the gene's overall role in diabetes is strong, it is important to note that genetic associations are statistical in nature. Having a specific genotype does not mean an individual will develop a condition; rather, it indicates a higher or lower statistical probability compared to the general population. Research into these variants is ongoing, and scientists continue to explore how these genetic markers interact with lifestyle factors, such as diet and physical activity, to influence metabolic health outcomes.
Population Frequency and Interpretation
The rs6718711 variant is considered common, meaning it is found at significant frequencies across various ancestral populations. Because it is a common variant, many people carry one or more copies of the alleles associated with it. When interpreting this information, it is helpful to remember that genetic risk is complex and polygenic, meaning it involves the interaction of many different genes and environmental factors. A single SNP like rs6718711 provides only a small piece of the puzzle. It is not a diagnostic tool and cannot predict an individual's health outcome with certainty. Understanding your genetic profile can be an educational experience, but it should not replace professional medical advice or screening.
What You Can Do With This Information
If you have learned about your genotype for rs6718711, the most productive step is to use it as a conversation starter with your healthcare provider. Genetic information is best understood in the context of your overall health history, including your blood sugar levels, family history, and lifestyle habits. You cannot change your genotype, but you can focus on modifiable factors that support metabolic health, such as maintaining a balanced diet and regular exercise. If you are concerned about diabetes risk, ask your doctor about appropriate screenings, such as an A1C test or a fasting glucose test. Never use genetic data to make decisions about medication or to self-diagnose; always consult with a clinician or pharmacist regarding any medical concerns or changes to your health regimen.
How common is this variant?
The rs6718711 variant is a common polymorphism, with its alleles appearing at significant frequencies across diverse global populations.
Frequently asked questions
Does having a TCF7L2 variant mean I will get diabetes?
No, having a specific genotype does not mean you will develop diabetes. Genetic variants are just one of many factors, including lifestyle and environment, that influence your health.
Can I change my TCF7L2 genotype?
No, your genetic sequence is determined at conception and cannot be changed. However, you can manage your health through diet, exercise, and regular medical check-ups.
Should I take medication based on my TCF7L2 results?
No. You should never start, stop, or change any medication based on genetic test results without consulting your doctor or pharmacist first.
Is TCF7L2 the only gene linked to diabetes?
No, type 2 diabetes is a complex condition influenced by many different genes, as well as environmental and lifestyle factors. TCF7L2 is simply one of the most well-studied markers.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6718711?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.